GLP-1 weight loss drugs like Ozempic are linked to cosmetic concerns, including sagging earlobes, deflated breasts and ...

Here's how Williams underwent a significant weight loss in retirement.

The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become popular for weight loss, but results vary from person to ...

A recent study found that setting personal weight loss goals when using Zepbound or Mounjaro may lead to better results.

Ozempic transformed obesity treatment, but experts believe the next wave of therapies could have an even greater impact. The ...

Lilly said people on the next-generation weight loss medication across three different dosages achieved weight loss of 19% to 28%.

The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or ...

A woman in her late forties lost 10 kilograms through diet and exercise, only to see her progress stall despite maintaining the same routine. Experts say this common phenomenon is driven by biological ...

Sometimes, seeing isn’t believing. Across the country, Americans are losing weight faster than ever thanks to blockbuster obesity drugs like Wegovy and Zepbound, with roughly one in eight US adults ...

Think willpower is the only way to maintain weight loss? Think again. A new study reveals how a specific gut bacteria ...

The results of two phase 3 trials investigating Survodutide, a weight loss drug from Boehringer Ingelheim, suggest that the ...